Distinct features in natural history and outcomes of acute hepatitis C.

Although the difference did not reach statistical significance, this could reflect reinfection or superinfection previously reported among recently HCV-infected patients with ongoing IDU. 41 Overall, SVR was achieved in 80% upon initial therapy and in an additional 2/2 patients with repeat therapy (overall 90% in treated patients) regardless of IL28B genotype.

also in 111,027 other papers